BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26163603)

  • 1. Colorectal Cancer Patient Characteristics, Treatment and Survival in Oman--a Single Center Study.
    Kumar S; Burney IA; Zahid KF; D Souza PC; Belushi MA; Mufti TD; Meki WA; Furrukh M; Moundhri MS
    Asian Pac J Cancer Prev; 2015; 16(12):4853-8. PubMed ID: 26163603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases.
    Tokoro T; Okuno K; Hida JC; Ueda K; Yoshifuji T; Daito K; Sugiura F
    Clin Colorectal Cancer; 2014 Dec; 13(4):226-31. PubMed ID: 25442813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital.
    Techawathanawanna S; Nimmannit A; Akewanlop C
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S189-98. PubMed ID: 22574549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
    Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
    Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
    Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
    World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological characteristics and prognosis analysis of colorectal synchronous multiple primary cancer].
    Niu L; Zhang J; Liu T; Wu T; Chen W; Jiang Y; Wu Y; Wang P; Pan Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):41-45. PubMed ID: 29354898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
    Magaji BA; Moy FM; Roslani AC; Law CW
    BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
    Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P
    Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
    Alzahrani NA; Valle SJ; Fisher OM; Sugarbaker PH; Yonemura Y; Glehen O; Goere D; Honore C; Brigand C; de Hingh I; Verwaal VJ; Deraco M; Baratti D; Kusamura S; Pocard M; Piso P; Maerz L; Marchal F; Moran B; Levine EA; Dumont F; Pezet D; Abboud K; Kozman MA; Liauw W; Morris DL;
    J Surg Oncol; 2019 Mar; 119(3):336-346. PubMed ID: 30554404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Dose Reductions, Delays Between Chemotherapy Cycles, and/or Shorter Courses of Adjuvant Chemotherapy in Stage II and III Colorectal Cancer Patients: a Single-Center Retrospective Study.
    Sgouros J; Aravantinos G; Kouvatseas G; Rapti A; Stamoulis G; Bisvikis A; Res H; Samantas E
    J Gastrointest Cancer; 2015 Dec; 46(4):343-9. PubMed ID: 26143067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
    Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
    J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
    Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.
    Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spilioitis J; Torres-Melero J; Turaga K; Trout R
    Ann Surg Oncol; 2014 Dec; 21(13):4195-201. PubMed ID: 24854493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
    Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S;
    Oncology; 2013; 84(1):14-21. PubMed ID: 23076023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers.
    de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Kalady MF; Geisler D; Dietz D; Lavery IC; Remzi FH; Fazio VW
    Ann Surg Oncol; 2010 Jul; 17(7):1758-66. PubMed ID: 20131015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases.
    Xu KY; Gao H; Lian ZJ; Ding L; Li M; Gu J
    World J Surg Oncol; 2017 Jan; 15(1):25. PubMed ID: 28088224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.